Presentation Information

[O1-06]From Basic Research to Clinical Trials: Proposing a Comprehensive ELSI Framework for Vaccine Development in Japan

*Kaori Muto1 (1. Institute of Medical Science, The University of Tokyo (Japan))

Login required to view

Login is required to view some content.

Comment

To browse or post comments, you must log in.Log in